Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers
- Corresponding Author:
- Barbara Borroni
UniversitÃ degli Studi di Brescia Pza Spedali Civili, 1 - 25100 Brescia, Italy
Email: [email protected]
Received date: August 04, 2014; Accepted date: November 05, 2014; Published date: November 12, 2014
Citation: Borroni B, Benussi A, Pilotto A, Gazzina S, Turrone R et al. (2014) Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers. J Alzheimers Dis Parkinsonism 4:168. doi: 10.4172/2161-0460.1000168
Copyright: 2014 Borroni B et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Progressive Supranuclear Palsy (PSP) is a neurodegenerative disorders characterised by a kinetic-rigid syndrome with ocular motor dysfunction, postural instability, and frontal lobe and bulbar dysfunction. In most of the cases, especially at early disease stages, diagnosis is still challenging. PSP signs and symptoms may indeed overlap with both dementing neurodegenerative syndromes and movement disorders. In the last few years, a better definition of clinical picture along with the identification of biological and neuroimaging markers have increased diagnostic accuracy. In the present work, we reviewed the current literature on PSP diagnosis and the usefulness of potential diagnostic markers.